Trial intelligence / Profile preview

Fumaria Parviflora for Uremic Pruritus in ESRD

NCT02671162Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Jul 2015
Primary completion
Oct 2015
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of fumaria parviflora in uremic pruritus (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Visual Analogue Scale at 3 months. Started Jul 2015; status: completed.

02

Drugs

fumaria parviflora
03

Conditions

uremic pruritus

Beyond the preview

Go deeper on NCT02671162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02671162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call